Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.

Tytuł:
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
Autorzy:
Wang JY; Curandis, New York, USA. Electronic address: .
Zhang W; Department of Gastroenterology, Affiliated Hospital of Guizhou Medical University, Guizhou, China.
Roehrl MW; Curandis, New York, USA.
Roehrl VB; Curandis, New York, USA.
Roehrl MH; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: .
Źródło:
Journal of autoimmunity [J Autoimmun] 2021 Jun; Vol. 120, pp. 102644. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Publication: London : Academic Press
Original Publication: London ; San Diego : Academic Press, c1988-
MeSH Terms:
Autoimmunity*
Autoantigens/*immunology
COVID-19/*immunology
Lung/*immunology
SARS-CoV-2/*physiology
Signal Transduction/*immunology
Virus Replication/*immunology
A549 Cells ; COVID-19/pathology ; Humans ; Lung/pathology ; Lung/virology
References:
Rheumatology (Oxford). 2020 May 1;59(5):1026-1030. (PMID: 31728542)
Front Immunol. 2020 Oct 02;11:587517. (PMID: 33123171)
J Autoimmun. 2007 Feb;28(1):7-18. (PMID: 17296285)
J Biol Chem. 1996 Aug 2;271(31):18767-74. (PMID: 8702533)
J Proteomics. 2013 Apr 26;82:263-73. (PMID: 23500132)
Transl Res. 2016 May;171:17-28.e1-2. (PMID: 26772958)
J Immunol. 2017 Sep 1;199(5):1596-1605. (PMID: 28754682)
Clin Proteomics. 2017 Feb 1;14:6. (PMID: 28184180)
Rheumatology (Oxford). 2002 May;41(5):531-4. (PMID: 12011376)
Arthritis Rheum. 2012 Jan;64(1):213-21. (PMID: 21905010)
Clin Cancer Res. 2000 Oct;6(10):3949-56. (PMID: 11051243)
Reprod Biomed Online. 2011 Oct;23(4):471-83. (PMID: 21890413)
Int J Mol Sci. 2020 Dec 19;21(24):. (PMID: 33352757)
Am J Pathol. 2011 May;178(5):2177-90. (PMID: 21514432)
Arthritis Rheumatol. 2021 Feb;73(2):315-323. (PMID: 33241644)
J Biol Chem. 1998 Dec 25;273(52):35362-70. (PMID: 9857079)
Sci Rep. 2018 Mar 19;8(1):4852. (PMID: 29556082)
Clin Exp Immunol. 1981 Jan;43(1):87-93. (PMID: 6788413)
Front Immunol. 2022 Mar 24;13:831849. (PMID: 35401574)
Cell Death Differ. 1999 Oct;6(10):976-86. (PMID: 10556975)
Arthritis Rheum. 1990 Aug;33(8):1273-8. (PMID: 2390129)
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3625-9. (PMID: 1314395)
Clin Transl Immunology. 2020 Feb 29;9(3):e01101. (PMID: 32140226)
Arthritis Care Res (Hoboken). 2014 Apr;66(4):575-84. (PMID: 24023044)
N Engl J Med. 2020 Jul 16;383(3):288-290. (PMID: 32369280)
Pathog Dis. 2013 Jun;68(1):12-9. (PMID: 23620386)
Mol Immunol. 2000 May;37(7):351-9. (PMID: 11074253)
Diabetes Metab J. 2016 Apr;40(2):154-60. (PMID: 26616590)
Clin Exp Immunol. 1993 May;92(2):263-7. (PMID: 7683587)
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):33-42. (PMID: 28032847)
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5186-9. (PMID: 2455896)
Sci Rep. 2019 Jul 30;9(1):11059. (PMID: 31363116)
Am J Respir Crit Care Med. 2008 May 15;177(10):1128-34. (PMID: 18276943)
Urine (Amst). 2020;2:1-8. (PMID: 33688631)
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. (PMID: 32428392)
Ann Rheum Dis. 2009 Oct;68(10):1621-5. (PMID: 18930994)
Clin Proteomics. 2020 Sep 21;17:35. (PMID: 32973414)
J Immunol. 1994 Sep 1;153(5):2268-77. (PMID: 7519647)
Clin Rheumatol. 2018 May;37(5):1229-1237. (PMID: 29427009)
J Peripher Nerv Syst. 2012 Mar;17(1):62-71. (PMID: 22462667)
Transpl Int. 2005 May;17(12):834-40. (PMID: 15711981)
Nephrol Dial Transplant. 2014 Jun;29(6):1168-77. (PMID: 24319012)
J Clin Invest. 2000 Jul;106(1):137-44. (PMID: 10880057)
Clin Exp Immunol. 1995 Apr;100(1):67-74. (PMID: 7697925)
Cancer Res. 2004 Aug 1;64(15):5089-96. (PMID: 15289310)
Biochem Med (Zagreb). 2016;26(2):272-8. (PMID: 27346975)
Nat Med. 2020 Jun;26(6):842-844. (PMID: 32398875)
Gastroenterology. 1998 May;114(5):912-22. (PMID: 9558279)
Rheumatology (Oxford). 2000 Oct;39(10):1114-20. (PMID: 11035132)
Mol Immunol. 1996 Oct;33(15):1171-6. (PMID: 9070665)
Int J Urol. 2006 Mar;13(3):211-7. (PMID: 16643611)
J Rheumatol. 1999 Aug;26(8):1715-20. (PMID: 10451067)
Immunol Res. 2017 Dec;65(6):1110-1123. (PMID: 28913776)
J Transl Autoimmun. 2020;3:100073. (PMID: 33263103)
Arthritis Rheum. 2013 Apr;65(4):869-79. (PMID: 23400887)
Eur J Biochem. 1997 Jan 15;243(1-2):209-18. (PMID: 9030741)
Emerg Microbes Infect. 2020 Dec;9(1):1748-1760. (PMID: 32691695)
Arthritis Rheum. 2011 Jul;63(7):1972-8. (PMID: 21425128)
Invest Ophthalmol Vis Sci. 2001 May;42(6):1273-6. (PMID: 11328739)
Scand J Immunol. 2006 May;63(5):376-82. (PMID: 16640662)
Nat Genet. 2015 Jun;47(6):654-60. (PMID: 25894502)
Microbiol Immunol. 2005;49(1):57-65. (PMID: 15665454)
Arthritis Res. 2000;2(5):407-14. (PMID: 11056675)
J Am Soc Nephrol. 2012 Mar;23(3):556-66. (PMID: 22323643)
Proteomics. 2006 Sep;6(17):4781-9. (PMID: 16878294)
Biochem Biophys Res Commun. 2004 Oct 15;323(2):518-22. (PMID: 15369782)
Autoimmunity. 1993;14(3):243-9. (PMID: 8329561)
Lupus. 2014 Sep;23(10):1031-41. (PMID: 24836587)
Br J Cancer. 2002 Jul 29;87(3):339-43. (PMID: 12177805)
Clin Rheumatol. 2020 Nov;39(11):3171-3175. (PMID: 32844364)
Pancreatology. 2019 Jul;19(5):760-768. (PMID: 31255446)
PLoS One. 2019 Jun 25;14(6):e0219018. (PMID: 31237920)
J Immunol. 2014 Sep 15;193(6):3080-9. (PMID: 25135833)
RNA. 2002 Jun;8(6):762-71. (PMID: 12088149)
J Invest Dermatol. 1990 Sep;95(3):304-8. (PMID: 2384689)
Emerg Microbes Infect. 2020 Dec;9(1):761-770. (PMID: 32228226)
J Neuroimmunol. 2015 Jul 15;284:30-6. (PMID: 26025055)
PLoS Negl Trop Dis. 2010 Jun 15;4(6):e710. (PMID: 20559541)
Biochem Biophys Res Commun. 1998 Jan 14;242(2):267-71. (PMID: 9446782)
J Virol. 2020 Sep 15;94(19):. (PMID: 32699094)
J Immunol. 2018 Jan 15;200(2):523-537. (PMID: 29229678)
J Neuroinflammation. 2015 Sep 17;12:168. (PMID: 26377319)
J Am Soc Nephrol. 2015 Aug;26(8):1905-24. (PMID: 25398787)
Clin Cancer Res. 2009 Jul 15;15(14):4733-41. (PMID: 19584157)
Ann Rheum Dis. 2001 Jan;60(1):72-6. (PMID: 11114288)
Mol Cell Proteomics. 2011 Jun;10(6):M110.005330. (PMID: 21474795)
Clin Exp Immunol. 1992 Dec;90(3):422-7. (PMID: 1458678)
Genes Dev. 1993 Jul;7(7A):1176-90. (PMID: 8319909)
Br J Haematol. 2013 Feb;160(3):359-62. (PMID: 23116149)
Cell Mol Immunol. 2020 Sep;17(9):998-1000. (PMID: 32728199)
J Biol Chem. 2004 Dec 10;279(50):52425-36. (PMID: 15456758)
J Autoimmun. 2003 May;20(3):237-45. (PMID: 12753809)
Proteomics Clin Appl. 2015 Dec;9(11-12):1012-20. (PMID: 25824007)
Eur J Immunol. 2000 Dec;30(12):3575-84. (PMID: 11169399)
Medicine (Baltimore). 2016 Aug;95(35):e4713. (PMID: 27583908)
J Neuroimmunol. 2018 Apr 15;317:77-83. (PMID: 29338928)
Arthritis Rheumatol. 2015 Jul;67(7):1913-21. (PMID: 25917817)
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3343-7. (PMID: 1849652)
J Virol. 2014 Nov;88(21):12511-27. (PMID: 25142582)
J Exp Med. 1998 Feb 16;187(4):547-60. (PMID: 9463405)
J Rheumatol. 2002 Jan;29(1):90-3. (PMID: 11824977)
Cancer Biomark. 2020;27(2):207-211. (PMID: 31839604)
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6038-42. (PMID: 2527369)
J Mol Recognit. 2018 Jul;31(7):e2703. (PMID: 29457292)
Rheumatology (Oxford). 2017 May 1;56(5):829-834. (PMID: 28064210)
Muscle Nerve. 2020 Sep;62(3):333-343. (PMID: 32483837)
Rheumatology (Oxford). 2010 Dec;49(12):2255-63. (PMID: 20716673)
Front Biosci (Landmark Ed). 2020 Jan 1;25(5):912-929. (PMID: 31585923)
Int Heart J. 2007 May;48(3):407-15. (PMID: 17592206)
Science. 2020 Oct 23;370(6515):. (PMID: 32972996)
Cell. 2020 Aug 6;182(3):685-712.e19. (PMID: 32645325)
Neurol Sci. 2013 Mar;34(3):313-20. (PMID: 22391679)
Ann Clin Biochem. 2008 Jan;45(Pt 1):65-9. (PMID: 18275676)
J Androl. 2004 Sep-Oct;25(5):699-705. (PMID: 15292099)
Arthritis Res Ther. 2016 Apr 01;18:76. (PMID: 27037016)
J Hematol Oncol. 2013 Sep 06;6:67. (PMID: 24010981)
Croat Med J. 2014 Jun 1;55(3):259-64. (PMID: 24891284)
J Neuroimmunol. 2007 Mar;184(1-2):223-6. (PMID: 17161872)
J Clin Invest. 1992 Jul;90(1):165-73. (PMID: 1378852)
Cell Death Differ. 2008 Apr;15(4):793-804. (PMID: 18202700)
Immunogenetics. 2016 Apr;68(4):237-46. (PMID: 26743536)
Clin Exp Immunol. 1997 May;108(2):181-90. (PMID: 9158084)
EMBO Mol Med. 2020 Dec 7;12(12):e13001. (PMID: 33078545)
Fertil Steril. 2010 Dec;94(7):2636-41. (PMID: 20522323)
Amyotroph Lateral Scler. 2011 Nov;12(6):430-8. (PMID: 22023190)
J Clin Immunol. 2016 May;36(4):377-387. (PMID: 27048656)
Rheumatology (Oxford). 2008 Feb;47(2):165-71. (PMID: 18208821)
Bioinformatics. 2020 Apr 15;36(8):2628-2629. (PMID: 31882993)
J Immunol. 2002 Feb 15;168(4):2054-62. (PMID: 11823543)
J Autoimmun. 2006 May;26(3):197-207. (PMID: 16549322)
J Toxicol Sci. 1994 Aug;19(3):163-9. (PMID: 7966454)
Ann Neurol. 2017 Feb;81(2):266-277. (PMID: 28074593)
Oncotarget. 2018 Jan 1;9(26):18559-18569. (PMID: 29719626)
Blood Transfus. 2020 Jul;18(4):328. (PMID: 32697931)
PLoS Biol. 2020 Sep 8;18(9):e3000849. (PMID: 32898168)
Mol Biosyst. 2017 Jun 1;13(6):1090-1101. (PMID: 28426042)
BMC Immunol. 2017 Jun 26;18(1):34. (PMID: 28651547)
Am J Reprod Immunol. 2012 Nov;68(5):438-49. (PMID: 22935024)
Front Immunol. 2021 May 25;12:680212. (PMID: 34113352)
J Immunol. 2010 Apr 1;184(7):4025-32. (PMID: 20194725)
Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1195-1201. (PMID: 29397435)
Mol Cell. 2020 Oct 1;80(1):164-174.e4. (PMID: 32877642)
Transfusion. 2015 Dec;55(12):2930-8. (PMID: 26259504)
Ann Rheum Dis. 2016 Nov;75(11):2022-2028. (PMID: 26865600)
PLoS One. 2013 Aug 19;8(8):e72458. (PMID: 23977302)
PLoS One. 2015 Dec 30;10(12):e0145323. (PMID: 26717306)
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. (PMID: 30476243)
Nat Med. 2020 Jul;26(7):1070-1076. (PMID: 32514174)
Mikrochim Acta. 2018 Apr 23;185(5):262. (PMID: 29687337)
J Rheumatol. 2004 Nov;31(11):2142-50. (PMID: 15517625)
J Clin Invest. 1995 Mar;95(3):1306-15. (PMID: 7533788)
Rheumatol Int. 2012 May;32(5):1335-42. (PMID: 21298269)
Arthritis Rheum. 2000 Mar;43(3):689-98. (PMID: 10728764)
Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1033-1042. (PMID: 33124564)
Rheumatology (Oxford). 2015 Feb;54(2):349-58. (PMID: 25172934)
Arthritis Res Ther. 2019 Feb 18;21(1):62. (PMID: 30777133)
J Neuroophthalmol. 2020 Sep;40(3):398-402. (PMID: 32604245)
Endocr J. 2015;62(2):153-60. (PMID: 25346144)
Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):137-46. (PMID: 18696130)
Am J Pathol. 2011 May;178(5):2168-76. (PMID: 21514431)
Biochem Biophys Res Commun. 1990 Oct 30;172(2):496-502. (PMID: 2241950)
Clin Cosmet Investig Dermatol. 2016 Sep 23;9:291-295. (PMID: 27729809)
Arthritis Rheumatol. 2016 Nov;68(11):2708-2716. (PMID: 27213890)
Hum Reprod. 2012 Feb;27(2):408-17. (PMID: 22158085)
J Clin Invest. 1993 Jun;91(6):2556-64. (PMID: 8514867)
J Invest Dermatol. 2003 Mar;120(3):365-71. (PMID: 12603848)
Curr Neurovasc Res. 2012 Nov;9(4):296-301. (PMID: 23030505)
Onco Targets Ther. 2013;6:273-9. (PMID: 23569391)
BMC Cancer. 2014 Jun 18;14:452. (PMID: 24946857)
Immunol Lett. 1989 Nov;23(1):35-41. (PMID: 2606513)
Arthritis Rheum. 2013 Jan;65(1):69-80. (PMID: 23044660)
Transl Psychiatry. 2013 Jul 09;3:e277. (PMID: 23838888)
ACS Infect Dis. 2020 Dec 11;6(12):3174-3189. (PMID: 33263384)
Sci Transl Med. 2017 Jul 5;9(397):. (PMID: 28679661)
Cell. 2020 Nov 12;183(4):982-995.e14. (PMID: 32991843)
Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1109-15. (PMID: 9865429)
J Biol Chem. 2000 Jun 2;275(22):17122-9. (PMID: 10747894)
Dis Markers. 2016;2016:5128720. (PMID: 27847402)
J Clin Oncol. 2008 Nov 1;26(31):5060-6. (PMID: 18794547)
Arthritis Rheum. 2003 Jan;48(1):210-7. (PMID: 12528121)
Cell. 2020 May 28;181(5):1036-1045.e9. (PMID: 32416070)
J Med Virol. 2005 Aug;76(4):464-9. (PMID: 15977250)
Nat Commun. 2019 Apr 3;10(1):1523. (PMID: 30944313)
Front Immunol. 2018 Oct 02;9:2090. (PMID: 30333817)
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. (PMID: 30208379)
J Virol. 2003 Oct;77(19):10584-93. (PMID: 12970443)
PLoS One. 2019 Dec 5;14(12):e0226162. (PMID: 31805175)
Toxicol Appl Pharmacol. 2009 Nov 1;240(3):393-400. (PMID: 19647757)
PLoS One. 2013;8(3):e58095. (PMID: 23483977)
Clin Rev Allergy Immunol. 2011 Jun;40(3):151-8. (PMID: 20414746)
Transplantation. 2011 Oct 15;92(7):829-35. (PMID: 21869741)
Clin Exp Immunol. 1994 Mar;95(3):385-9. (PMID: 8137536)
Inflamm Bowel Dis. 2011 Feb;17(2):557-64. (PMID: 20629101)
Clin Exp Immunol. 1995 May;100(2):198-204. (PMID: 7743655)
Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202)
Biochim Biophys Acta. 1987 Apr 22;928(2):217-26. (PMID: 2436670)
Mol Cell Proteomics. 2002 Mar;1(3):197-203. (PMID: 12096119)
PLoS One. 2011;6(10):e26515. (PMID: 22022619)
Nature. 2020 Jul;583(7816):469-472. (PMID: 32408336)
Thromb Res. 2014 Feb;133(2):222-8. (PMID: 24331211)
mBio. 2016 Mar 29;7(2):e00029. (PMID: 27025248)
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1777-81. (PMID: 2308937)
Cell. 2020 Jul 9;182(1):59-72.e15. (PMID: 32492406)
Mol Immunol. 2009 Dec;47(2-3):511-6. (PMID: 19747733)
Arthritis Res Ther. 2010;12(3):120. (PMID: 20537203)
Oncoimmunology. 2017 Mar 31;6(5):e1310359. (PMID: 28638733)
Nature. 2020 Jul;583(7816):459-468. (PMID: 32353859)
J Proteomics. 2017 Mar 22;157:59-70. (PMID: 28137667)
J Immunol. 1988 Nov 1;141(9):3135-41. (PMID: 2459243)
FASEB J. 2020 Jun;34(6):8459-8474. (PMID: 32362042)
Cancers (Basel). 2020 Nov 25;12(12):. (PMID: 33255653)
Nucleic Acids Res. 1998 Jan 15;26(2):439-45. (PMID: 9421497)
J Neuroimmunol. 2011 Aug 15;237(1-2):87-92. (PMID: 21774995)
Clin Exp Rheumatol. 2019 May-Jun;37(3):474-480. (PMID: 30418114)
BMC Immunol. 2019 Jun 26;20(1):21. (PMID: 31242852)
J Clin Invest. 1994 Jul;94(1):184-92. (PMID: 8040259)
Nature. 2020 Oct;586(7827):113-119. (PMID: 32707573)
Front Microbiol. 2020 Nov 25;11:593857. (PMID: 33324374)
J Am Soc Nephrol. 2010 Mar;21(3):507-19. (PMID: 20150532)
J Transl Med. 2018 Jun 28;16(1):177. (PMID: 29954402)
Neurochem Res. 1990 Apr;15(4):401-6. (PMID: 1697040)
Nat Immunol. 2020 Sep;21(9):1107-1118. (PMID: 32788748)
Grant Information:
P30 CA008748 United States CA NCI NIH HHS; R21 CA251992 United States CA NCI NIH HHS
Contributed Indexing:
Keywords: Atlas; Autoantigens; Autoimmunity; COVID-19; Lung; Resource
Substance Nomenclature:
0 (Autoantigens)
Entry Date(s):
Date Created: 20210510 Date Completed: 20210524 Latest Revision: 20221221
Update Code:
20240105
PubMed Central ID:
PMC8075847
DOI:
10.1016/j.jaut.2021.102644
PMID:
33971585
Czasopismo naukowe
We aim to establish a comprehensive COVID-19 autoantigen atlas in order to understand autoimmune diseases caused by SARS-CoV-2 infection. Based on the unique affinity between dermatan sulfate and autoantigens, we identified 348 proteins from human lung A549 cells, of which 198 are known targets of autoantibodies. Comparison with current COVID data identified 291 proteins that are altered at protein or transcript level in SARS-CoV-2 infection, with 191 being known autoantigens. These known and putative autoantigens are significantly associated with viral replication and trafficking processes, including gene expression, ribonucleoprotein biogenesis, mRNA metabolism, translation, vesicle and vesicle-mediated transport, and apoptosis. They are also associated with cytoskeleton, platelet degranulation, IL-12 signaling, and smooth muscle contraction. Host proteins that interact with and that are perturbed by viral proteins are a major source of autoantigens. Orf3 induces the largest number of protein alterations, Orf9 affects the mitochondrial ribosome, and they and E, M, N, and Nsp proteins affect protein localization to membrane, immune responses, and apoptosis. Phosphorylation and ubiquitination alterations by viral infection define major molecular changes in autoantigen origination. This study provides a large list of autoantigens as well as new targets for future investigation, e.g., UBA1, UCHL1, USP7, CDK11A, PRKDC, PLD3, PSAT1, RAB1A, SLC2A1, platelet activating factor acetylhydrolase, and mitochondrial ribosomal proteins. This study illustrates how viral infection can modify host cellular proteins extensively, yield diverse autoantigens, and trigger a myriad of autoimmune sequelae. Our work provides a rich resource for studies into "long COVID" and related autoimmune sequelae.
(Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Update of: bioRxiv. 2021 Feb 22;:. (PMID: 33655248)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies